Skip to main content

Location

Texas Medical Center

Specialty
Cancer
Phone: 832-824-4588
Fax: 832-825-4039
Email

sberg@texaschildrens.org

Address

1102 Bates Ave., Ste. 1550.06
Houston, TX 77030

Stacey L. Berg, MD

Director, Palliative Care Program
Director, Developmental Therapeutics Program
Associate Dean for Research Assurances, Baylor College of Medicine
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine

Education

School Education Degree Year
NIH/NCI fellowship Pediatric Hematology-Oncology 1994
University of Pittsburgh School of Medicine residency Pediatrics 1988
University of Pittsburgh School of Medicine internship Pediatrics 1986
University of Pittsburgh School of Medicine medical school Doctor of Medicine 1985
Harvard University bachelors Bachelor of Arts 1981

About

Dr. Stacey Berg is a pediatric oncologist specializing in the development of new anticancer drugs for children. She also has a strong interest in clinical trial design, biomedical ethics, and the incorporation of palliative care principles into pediatric oncology practice.

Board Certifications
American Board of Pediatrics
American Board of Pediatrics, Pediatric Hematology and Oncology
American Board of Pediatrics, Hospice and Palliative Medicine

Journal Participation
Reviewer, AAPS Journal
Reviewer, Biochemical Pharmacology
Reviewer, Blood
Reviewer, Bone Marrow Transplantation
Reviewer, Cancer
Reviewer, Cancer Chemotherapy and Pharmacology
Reviewer, Cancer Research
Reviewer, Cell Death and Differentiation
Reviewer, Clinical Cancer Research
Reviewer, Comparative Medicine
Reviewer, European Journal of Cancer
Reviewer, Investigational New Drugs
Reviewer, Journal of Clinical Oncology
Reviewer, Journal of the National Cancer Institute
Reviewer, Journal of Pediatric Hematology/Oncology
Reviewer, New England Journal of Medicine
Reviewer, Journal of the National Cancer Institute

Elected Positions
Leadership, Regulatory Leader, Pediatric Early Phase Clinical Trials Network Steering Committee
Member, Pediatric Early Phase Clinical Trials Network Agent Prioritization Committee

 

Organization

Organization Name Role
American Academy of Hospice and Palliative Medicine Member
American Academy of Pediatrics (AAP) Member
American Association for Cancer Research (AACR) Member
American Pediatric Society Member
American Society Clinical Oncology (ASCO) Member
Children's Oncology Group (COG) Developmental Therapeutics Steering Committee

Research Statement

Dr. Stacey Berg’s primary research interest is in the design and conduct of early phase clinical trials of new anticancer agents. This process includes the evaluation of new agents against pediatric cancer targets in the laboratory, as well as preclinical pharmacokinetic studies. With these data, phase 1 studies are designed to determine the appropriate dose and schedule of new agents for use in children, as well as to obtain preliminary indications of activity. These results form the basis of subsequent larger scale clinical trials.

Awards

2015     Center for Medical Ethics and Health Policy Faculty Service Award, Baylor College of Medicine
2011     Highest Rated Lecture, ASCO/AACR Methods in Clinical Cancer Research Workshop
 

Language

English

Latest Videos

Medically Speaking: Cancer Clinical Trials, Stacey L. Berg, MD

Relapse & Developmental Therapeutics

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.